HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter J Osmond Selected Research

Glucocorticoid-Remediable Aldosteronism

1/2019Long-term BP control and vascular health in patients with hyperaldosteronism treated with low-dose, amiloride-based therapy.
1/2019Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter J Osmond Research Topics

Disease

2Hyperaldosteronism (Conn Syndrome)
01/2019 - 01/2019
2Glucocorticoid-Remediable Aldosteronism
01/2019 - 01/2019
1Vascular Diseases (Vascular Disease)
01/2019
1Hypertension (High Blood Pressure)
11/2012
1Heart Diseases (Heart Disease)
11/2012

Drug/Important Bio-Agent (IBA)

2Epithelial Sodium ChannelsIBA
01/2019 - 01/2019
2Amiloride (Midamor)FDA LinkGeneric
01/2019 - 01/2019
1AldosteroneIBA
01/2019
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2012
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2012

Therapy/Procedure

2Therapeutics
01/2019 - 01/2019